The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.
30s seems reasonable to me. My main focus is development over share price at the moment as I am not looking to relinquish my shares any time soon. So far in 2024 I have been very happy with the contracts/extensions we have received, hopefully we see more of the same in H2.
With the end now in sight for the Gaza conflict the share price will likely recover a bit. We have lost about 20% due to the war so will be interesting to see how much we recover
Yeh personally I am very happy with BATM's development so far in 2024. We likely see a discounted SP until the war ends which is fine by me as can continue to buy the stock cheap. Patience will most definitely be rewarded with BATM.
Extremely positive news for BATM as they have been selected for a prestigious EU-funded tuberculosis diagnostics program in collaboration with Italy's National Research Council. This partnership will help to develop rapid TB and multi-drug-resistant TB diagnostics. This could significantly enhance BATM's market position in a sector worth over $2bn.
Think many investors won't have the patience to wait for the tension to ease. I think we may continue to see a discounted price but all I know is the longer we stay at the lows, the larger the move will be in the future.
Very evident to me that the tensions in the Middle East are hampering the share price. In my view, the intrinsic value of the fundamentals massively exceeded the share price as investors are still worried, even though the conflict has not impacted their bottom line. If anything, the situation might even boost the company's revenue in their cybersecurity division.
Amazing news from the RNS today - BATM signed a significant new contract with Totalplay. Totalplay will utilise BATM's Edgility platform for the virtualisation, orchestration, and management of its enterprise connectivity services across its extensive fiber optic network. This deal marks a key milestone for Edgility as it transitions from proof of concept to full commercial rollout, demonstrating its competitiveness and flexibility in network virtualisation. Moti highlighted the agreement as validation of their strategy and a sign of strong future potential, with more contracts expected soon. Very exciting news for BATM investors as it clearly indicates strong progress in commercialisation and a bullish outlook for the SP.
Also very clear that BATM have made significant strides in quantum cyber encryption through Celare. For those that do not know Celare's development in quantum encryption harnesses the principles of quantum mechanics to create unbreakable cryptographic keys, ensuring data integrity and privacy. Their focus on practical implementation sets them apart, with solutions poised to revolutionise cybersecurity. As threats evolve, Celare's quantum-resistant algorithms offer a shield against future quantum computing risks
I completely agree, Resistance. The decision by BATM to divest its non-core businesses is very promising. It allows BATM to concentrate on its most profitable sectors (networking edge, cybersecurity, and diagnostics). Realistically, these are the businesses that will generate the most money for BATM and therefore more ROI for shareholders so its encouraging to see them dedicating all their efforts there.
Completely agree, an extension is proof of the quality of Edgility. Clearly clients are not disappointed and the retention rate will likely be very high. Bullish.
To be honest I am not even fussed about the SP as it will catch up with the fundamental value of the company soon enough. Main thing I want to see is new contract announcements and this extension from Cemex is exactly what I want to see. Good start to Q2 for BATM
Good article Nutmegmilk, clearly outlines a bullish outlook for BATM given its positive ROCE trend, which signifies improved profitability. Investors will be very encouraged by the 42% increase in capital employed over five years and the promising trends.
Very good news as BATM have secured $2.3 million in additional cyber security orders for its advanced solutions and is developing next-generation encryption with quantum key distribution for a government defence customer. This contributes to $35 million in orders over 15 months for the Cyber division. Moti also spoke about the continued momentum and confidence in integrating cutting-edge quantum technology. Very clear to see BATM are in a strong position in the cyber security market.
Been doing a lot of reading into Edgility recently, given the growth potential I wanted to educate myself a bit more about it. If anyone here has good articles on Edgility would be great if you could share the link.
This is why I am so focused on Edgility, the growth potential here is crazy not to mention the high margins. The dream scenario for a business if they play their cards right
Great read, thanks Resistance. Definitely worth a read for anyone that is looking to learn more about Edgility
Agreed resistance, was very happy with the investor presentation. Clear sales targets on Edgility and Natlab which I was very impressed with.
Good to have you back Nutmegmilk, I have also picked up some more mid 19s. My strategy is to hold onto them for 2 to 3 years. I anticipate that growth stocks will thrive once the UK emerges from this recession. With BATM's solid fundamentals, I'm optimistic that it will outperform other growth companies.
Given the positive news from year end results any price below 20 is a bargain. There is clear growth in their cyber and diagnostics revenue which is only going to continue. Investors need to be patient here. Will be keeping an eye on any new contracts over the next few quarters and to see what BATM do with their non-core divisions given they have adjusted their focus.
Good end of year results for BATM. Moti has successfully reorganised the core business activities and is ready to expand further as he has allocated resourced towards sales and looks to explore M&A opportunities in the US. Growth in the Cyber and Diagnostics divisions are very strong. I expect these to be money making machines for BATM over the next few years. The strong orders and product interest, indicates a promising outlook for 2024.